Trial
NCT00519831
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Bristol-Myers Squibb
Condition
Lung Cancer
Intervention
cetuximab
Why stopped
Drug unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-09